Double-headed arrow (between “Obstructive sleep apnea syndrome” and “Obesity”): This indicates a bidirectional relationship between Obstructive sleep apnea syndrome and obesity. Intermittent hypoxia ...
Mark Bleackley, PhD, chief scientific officer of Incannex, discusses in further detail the need for a pharmacotherapy like IHL-42X in obstructive sleep apnea (OSA) and the medication's underlying ...
Double-headed arrow (between “Obstructive sleep apnea syndrome” and “Obesity”): This indicates a bidirectional relationship between Obstructive sleep apnea syndrome and obesity. Intermittent hypoxia ...
An epilepsy drug sold in Europe as Ospolot and also known as sulthiame showed promise in reducing sleep disordered breathing and other symptoms of obstructive sleep apnea (OSA), based on data from ...
In a recent review article published in the journal Hypertension Research, researchers evaluate the relationship between the 'non-dipper' pattern of hypertension and obstructive sleep apnea (OSA) and ...
Obstructive sleep apnea (OSA) is a serious, chronic sleep-related breathing disease that impacts an estimated 80 million people in the United States and nearly 1 billion globally. Untreated OSA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results